The effect of an APOE polymorphism on cognitive function depends on age

Journal of Neurology

Volumn 261, Issue 1, 2014, Pages 66-72

  Shin, Min Ho ^a   Kweon, Sun Seog ^a,b   Choi, Jin Su ^a   Lee, Young Hoon ^c   Nam, Hae Sung ^d   Park, Kyeong Soo ^e   Kim, Hee N ^f   Song, Hye Rim ^a   Kim, Byeong C ^a   Choi, Seong Min ^a   Oh, Sun Young ^g   Jeong, Seul Ki ^g  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

^e Seonam University   (South Korea)

^f Chonnam National University   (South Korea)

^g Chonbuk National University Medical School   (South Korea)

Author keywords

Age; Apolipoprotein E; Cognition; Genetic polymorphism; K mMMSE

Indexed keywords

AGE FACTORS; AGED; AGING; APOLIPOPROTEIN E4; COGNITION; EDUCATIONAL STATUS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 84895073770     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7157-y     Document Type: Article

References (31)

1. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Gen 39:17-23
2. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
3. Liu F, Pardo LM, Schuur M, Sanchez-Juan P, Isaacs A, Sleegers K, de Koning I, Zorkoltseva IV, Axenovich TI, Witteman JC, Janssens AC, van Swieten JC, Aulchenko YS, Oostra BA, van Duijn CM (2010) The apolipoprotein E gene and its age-specific effects on cognitive function. Neurobiol Aging 31:1831-1833
4. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 361:255-263
5. Izaks GJ, Gansevoort RT, van der Knaap AM, Navis G, Dullaart RP, Slaets JP (2011) The association of APOE genotype with cognitive function in persons aged 35 years or older. PLoS One 6:e27415
6. Kweon SS, Shin MH, Jeong SK, Nam HS, Lee YH, Park KS, Ryu SY, Choi SW, Kim BH, Rhee JA, Zheng W, Choi JS (2013) Cohort profile: the Namwon study and the Dong-gu study. Int J Epidemiol. doi: 10.1093/ije/dys244
7. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548
8. Shin MH, Kim HN, Cui LH, Kweon SS, Park KS, Heo H, Nam HS, Jeong SK, Chung EK, Choi JS (2005) The effect of apolipoprotein E polymorphism on lipid levels in Korean adults. J Korean Med Sci 20:361-366
9. Jeong SK, Cho KH, Kim JM (2004) The usefulness of the Korean version of modified mini-mental state examination (K-mMMSE) for dementia screening in community dwelling elderly people. BMC Pub Heal 4:31
10. Jeong SK, Lim ES, Nam HS, Kweon SS, Park KS, Shin MH, Choi JS (2007) Population-based norms for the Korean mini-mental state examination and Korean version of modified mini-mental state examination. J Korean Neurol Assoc 25:1-9
11. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699
12. Small BJ, Rosnick CB, Fratiglioni L, Backman L (2004) Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 19:592-600
13. Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 55:1777-1785
14. Seeman TE, Huang MH, Bretsky P, Crimmins E, Launer L, Guralnik JM (2005) Education and APOE-e4 in longitudinal cognitive decline: Macarthur studies of successful Aging. J Gerontol B Psychol Sci Soc Sci 60:P74-P83
15. Ruiz A, Hernandez I, Ronsende-Roca M, Gonzalez-Perez A, Rodriguez-Noriega E, Ramirez-Lorca R, Mauleon A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayan J, Becker JT, Real LM, Tarraga L, Ballard C, Terrin M, Sherman S, Payami H, Lopez OL, Mintzer JE, Boada M (2013) Exploratory analysis of seven Alzheimer's disease genes: disease progression. Neurobiol Aging 34(1310):e1311-e1317
16. Morishima-Kawashima M, Oshima N, Ogata H, Yamaguchi H, Yoshimura M, Sugihara S, Ihara Y (2000) Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am J Pathol 157:2093-2099
17. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030-1035
18. Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM (2003) Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289:2094-2103
19. Koffie RM, Hashimoto T, Tai H-C, Kay KR, Serrano-Pozo A, Joyner D, Hou S, Kopeikina KJ, Frosch MP, Lee VM, Holtzman DM, Hyman BT, Spires-Jones TL (2012) Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. Brain 135:2155-2168
20. Canuet L, Tellado I, Couceiro V, Fraile C, Fernandez-Novoa L, Ishii R, Takeda M, Cacabelos R (2012) Resting-state network disruption and APOE genotype in Alzheimer's disease: a lagged functional connectivity study. PLoS One 7:e46289
21. Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ (2009) Fibrillar amyloid-beta burden in cognitively normal people at three levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 106:6820-6825
22. Rusted JM, Evans SL, King SL, Dowell N, Tabet N, Tofts PS (2013) APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures. Neuroimage 65:364-373
23. Han SD, Drake AI, Cessante LM, Jak AJ, Houston WS, Delis DC, Filoteo JV, Bondi MW (2007) Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism? J Neurol Neurosurg Psychiatry 78:1103-1108
24. Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, Boesiger P, Hock C, Nitsch RM, Papassotiropoulos A, Henke K (2007) Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 17:1934-1947
25. Yu YW, Lin CH, Chen SP, Hong CJ, Tsai SJ (2000) Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci Lett 294:179-181
26. Han SD, Bondi MW (2008) Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 4:251-254
27. Perrin RJ, Fagan AM, Holtzman DM (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461:916-922
28. Bunce D, Anstey KJ, Burns R, Christensen H, Easteal S (2011) Does possession of apolipoprotein E epsilon4 benefit cognitive function in healthy young adults? Neuropsychologia 49:1693-1697
29. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease Meta analysis consortium. JAMA 278:1349-1356
30. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487-495
31. Albin RL (1993) Antagonistic pleiotropy, mutation accumulation, and human genetic disease. Genetica 91:279-286